• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p62在炎症和癌症中多重作用的潜在机制

The Pathways Underlying the Multiple Roles of p62 in Inflammation and Cancer.

作者信息

Hennig Paulina, Fenini Gabriele, Di Filippo Michela, Karakaya Tugay, Beer Hans-Dietmar

机构信息

Department of Dermatology, University Hospital Zurich, Wagistrasse 18, CH-8952 Schlieren, Switzerland.

Faculty of Medicine, University of Zurich, CH-8032 Zurich, Switzerland.

出版信息

Biomedicines. 2021 Jun 22;9(7):707. doi: 10.3390/biomedicines9070707.

DOI:10.3390/biomedicines9070707
PMID:34206503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8301319/
Abstract

p62 is a highly conserved, multi-domain, and multi-functional adaptor protein critically involved in several important cellular processes. Via its pronounced domain architecture, p62 binds to numerous interaction partners, thereby influencing key pathways that regulate tissue homeostasis, inflammation, and several common diseases including cancer. Via binding of ubiquitin chains, p62 acts in an anti-inflammatory manner as an adaptor for the auto-, xeno-, and mitophagy-dependent degradation of proteins, pathogens, and mitochondria. Furthermore, p62 is a negative regulator of inflammasome complexes. The transcription factor Nrf2 regulates expression of a bundle of ROS detoxifying genes. p62 activates Nrf2 by interaction with and autophagosomal degradation of the Nrf2 inhibitor Keap1. Moreover, p62 activates mTOR, the central kinase of the mTORC1 sensor complex that controls cell proliferation and differentiation. Through different mechanisms, p62 acts as a positive regulator of the transcription factor NF-κB, a central player in inflammation and cancer development. Therefore, p62 represents not only a cargo receptor for autophagy, but also a central signaling hub, linking several important pro- and anti-inflammatory pathways. This review aims to summarize knowledge about the molecular mechanisms underlying the roles of p62 in health and disease. In particular, different types of tumors are characterized by deregulated levels of p62. The elucidation of how p62 contributes to inflammation and cancer progression at the molecular level might promote the development of novel therapeutic strategies.

摘要

p62是一种高度保守、具有多个结构域和多种功能的衔接蛋白,在多个重要的细胞过程中发挥关键作用。通过其独特的结构域架构,p62与众多相互作用伙伴结合,从而影响调节组织稳态、炎症以及包括癌症在内的几种常见疾病的关键信号通路。通过结合泛素链,p62作为一种衔接蛋白,以抗炎方式参与蛋白质、病原体和线粒体的自噬、异噬及线粒体自噬依赖性降解。此外,p62是炎性小体复合物的负调节因子。转录因子Nrf2调节一系列ROS解毒基因的表达。p62通过与Nrf2抑制剂Keap1相互作用并使其自噬体降解来激活Nrf2。此外,p62激活mTOR,mTOR是控制细胞增殖和分化的mTORC1传感复合物的中心激酶。通过不同机制,p62作为转录因子NF-κB的正调节因子,而NF-κB是炎症和癌症发展中的核心因子。因此,p62不仅是自噬的货物受体,也是一个中心信号枢纽,连接着几个重要的促炎和抗炎途径。本综述旨在总结关于p62在健康和疾病中作用的分子机制的知识。特别是,不同类型的肿瘤具有p62水平失调的特征。阐明p62在分子水平上如何促进炎症和癌症进展可能会推动新型治疗策略的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/0c9bbaf936dd/biomedicines-09-00707-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/fef5e4a69ba4/biomedicines-09-00707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/13604ade9b71/biomedicines-09-00707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/be4924857532/biomedicines-09-00707-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/0c9bbaf936dd/biomedicines-09-00707-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/fef5e4a69ba4/biomedicines-09-00707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/13604ade9b71/biomedicines-09-00707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/be4924857532/biomedicines-09-00707-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5133/8301319/0c9bbaf936dd/biomedicines-09-00707-g004.jpg

相似文献

1
The Pathways Underlying the Multiple Roles of p62 in Inflammation and Cancer.p62在炎症和癌症中多重作用的潜在机制
Biomedicines. 2021 Jun 22;9(7):707. doi: 10.3390/biomedicines9070707.
2
p62/SQSTM1: 'Jack of all trades' in health and cancer.p62/SQSTM1:健康与癌症领域的“多面手”。
FEBS J. 2019 Jan;286(1):8-23. doi: 10.1111/febs.14712. Epub 2018 Dec 18.
3
Toll-Like Receptor Signaling Induces Nrf2 Pathway Activation through p62-Triggered Keap1 Degradation.Toll样受体信号通过p62触发的Keap1降解诱导Nrf2通路激活。
Mol Cell Biol. 2015 Aug;35(15):2673-83. doi: 10.1128/MCB.00105-15. Epub 2015 May 26.
4
Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.p62 的磷酸化在选择性自噬过程中激活 Keap1-Nrf2 通路。
Mol Cell. 2013 Sep 12;51(5):618-31. doi: 10.1016/j.molcel.2013.08.003. Epub 2013 Sep 5.
5
p62-Nrf2-p62 Mitophagy Regulatory Loop as a Target for Preventive Therapy of Neurodegenerative Diseases.p62-Nrf2-p62线粒体自噬调节环作为神经退行性疾病预防性治疗的靶点
Brain Sci. 2020 Nov 12;10(11):847. doi: 10.3390/brainsci10110847.
6
p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.p62/SQSTM1——兼具抗氧化应激作用与促肝癌作用的“杰ekyll博士与海德先生”。 (注:这里“杰ekyll博士与海德先生”是用文学形象比喻p62/SQSTM1具有两种不同甚至相反特性的复杂情况 )
FEBS Lett. 2016 Aug;590(15):2375-97. doi: 10.1002/1873-3468.12301. Epub 2016 Aug 6.
7
p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.p62/SQSTM1作为一个信号枢纽和自噬衔接蛋白发挥作用。
FEBS J. 2015 Dec;282(24):4672-8. doi: 10.1111/febs.13540. Epub 2015 Oct 16.
8
Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy.治疗阿尔茨海默病的新靶点:Nrf2 通路与自噬的串扰。
Ageing Res Rev. 2021 Jan;65:101207. doi: 10.1016/j.arr.2020.101207. Epub 2020 Nov 1.
9
An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.一种与额颞叶痴呆相关的 SQSTM1 变体影响 Nrf2 和 NF-κB 信号通路,并与 p62 的磷酸化减少有关。
Mol Cell Neurosci. 2019 Jul;98:32-45. doi: 10.1016/j.mcn.2019.04.001. Epub 2019 Apr 4.
10
Emerging views of mitophagy in immunity and autoimmune diseases.线粒体自噬在免疫和自身免疫性疾病中的新观点。
Autophagy. 2020 Jan;16(1):3-17. doi: 10.1080/15548627.2019.1603547. Epub 2019 Apr 21.

引用本文的文献

1
TET1 functions as a tumor suppressor in lung adenocarcinoma through epigenetic remodeling and immune modulation.TET1通过表观遗传重塑和免疫调节在肺腺癌中发挥肿瘤抑制作用。
Epigenetics Chromatin. 2025 Aug 11;18(1):53. doi: 10.1186/s13072-025-00617-2.
2
Post-Translational Modification of p62: Roles and Regulations in Autophagy.p62的翻译后修饰:自噬中的作用与调控
Cells. 2025 Jul 2;14(13):1016. doi: 10.3390/cells14131016.
3
p62 mRNA suppresses NLRP1 expression in cutaneous SCC cells through miR-34a-5p.p62信使核糖核酸通过微小核糖核酸-34a-5p抑制皮肤鳞状细胞癌细胞中NLRP1的表达。

本文引用的文献

1
SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway.SQSTM1/p62通过调控AKT/AMPK/mTOR信号通路促进甲状腺乳头状癌的细胞生长并引发自噬。
Front Oncol. 2021 Apr 15;11:638701. doi: 10.3389/fonc.2021.638701. eCollection 2021.
2
The Role of mTOR Signaling as a Therapeutic Target in Cancer.mTOR 信号在癌症治疗中的作用。
Int J Mol Sci. 2021 Feb 9;22(4):1743. doi: 10.3390/ijms22041743.
3
MiT/TFE Family of Transcription Factors: An Evolutionary Perspective.
Cell Death Dis. 2025 Jul 1;16(1):465. doi: 10.1038/s41419-025-07785-9.
4
Autophagy and Alzheimer's Disease: Mechanisms and Impact Beyond the Brain.自噬与阿尔茨海默病:机制及脑外影响
Cells. 2025 Jun 16;14(12):911. doi: 10.3390/cells14120911.
5
mTOR promotes the formation and growth of tertiary lymphoid tissues in the kidney.mTOR促进肾脏中三级淋巴组织的形成和生长。
Front Immunol. 2025 May 27;16:1527817. doi: 10.3389/fimmu.2025.1527817. eCollection 2025.
6
Deciphering the dual role of autophagy in gastric cancer and gastroesophageal junction cancer: from tumor suppression to cancer progression.解读自噬在胃癌和胃食管交界癌中的双重作用:从肿瘤抑制到癌症进展。
Discov Oncol. 2025 Jun 5;16(1):1013. doi: 10.1007/s12672-025-02802-x.
7
Expression and Diagnostic Value of Nrf2 and p62 in Cervical Squamous Cell Carcinoma and Intraepithelial Lesions.Nrf2和p62在宫颈鳞状细胞癌及上皮内病变中的表达及诊断价值
Cancer Manag Res. 2025 May 24;17:1005-1013. doi: 10.2147/CMAR.S513226. eCollection 2025.
8
Therapeutic potential of fisetin in hepatic steatosis: Insights into autophagy pathway regulation and endoplasmic reticulum stress alleviation in high-fat diet-fed mice.非瑟酮对肝脂肪变性的治疗潜力:高脂饮食喂养小鼠自噬途径调节及内质网应激减轻的研究洞察
PLoS One. 2025 May 22;20(5):e0322335. doi: 10.1371/journal.pone.0322335. eCollection 2025.
9
Pomiferin Induces Antiproliferative and Pro-Death Effects in High-Risk Neuroblastoma Cells by Modulating Multiple Cell Death Pathways.波米黄素通过调节多种细胞死亡途径诱导高危神经母细胞瘤细胞的抗增殖和促死亡效应。
Int J Mol Sci. 2025 Apr 11;26(8):3600. doi: 10.3390/ijms26083600.
10
Usutu virus NS4A induces autophagy and is targeted by the selective autophagy receptor p62/SQSTM1 for degradation.乌苏图病毒NS4A诱导自噬,并被选择性自噬受体p62/SQSTM1靶向降解。
Virol J. 2025 Apr 17;22(1):103. doi: 10.1186/s12985-025-02719-5.
转录因子的MiT/TFE家族:进化视角
Front Cell Dev Biol. 2021 Jan 6;8:609683. doi: 10.3389/fcell.2020.609683. eCollection 2020.
4
p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response.p62/SQSTM1 液滴可作为自噬体形成和抗氧化应激反应的平台。
Nat Commun. 2021 Jan 4;12(1):16. doi: 10.1038/s41467-020-20185-1.
5
Structure and function of p62/SQSTM1 in the emerging framework of phase separation.泛素结合蛋白 p62/SQSTM1 在液-液相分离新兴框架中的结构与功能
FEBS J. 2021 Dec;288(24):6927-6941. doi: 10.1111/febs.15672. Epub 2020 Dec 30.
6
Interplay Between NLRP3 Inflammasome and Autophagy.NLRP3炎症小体与自噬之间的相互作用
Front Immunol. 2020 Oct 9;11:591803. doi: 10.3389/fimmu.2020.591803. eCollection 2020.
7
The multifaceted functions of ATG16L1 in autophagy and related processes.ATG16L1在自噬及相关过程中的多方面功能。
J Cell Sci. 2020 Oct 30;133(20):jcs249227. doi: 10.1242/jcs.249227.
8
Extracellular SQSTM1 as an inflammatory mediator.细胞外 SQSTM1 作为一种炎症介质。
Autophagy. 2020 Dec;16(12):2313-2315. doi: 10.1080/15548627.2020.1843253. Epub 2020 Dec 8.
9
A Role for the Autophagic Receptor, SQSTM1/p62, in Trafficking NF-κB/RelA to Nucleolar Aggresomes.自噬受体 SQSTM1/p62 在将 NF-κB/RelA 转运到核仁聚集物中的作用。
Mol Cancer Res. 2021 Feb;19(2):274-287. doi: 10.1158/1541-7786.MCR-20-0336. Epub 2020 Oct 23.
10
Extracellular SQSTM1 mediates bacterial septic death in mice through insulin receptor signalling.细胞外 SQSTM1 通过胰岛素受体信号转导介导小鼠脓毒症死亡。
Nat Microbiol. 2020 Dec;5(12):1576-1587. doi: 10.1038/s41564-020-00795-7. Epub 2020 Oct 19.